THE PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE DEMONSTRATES EXCELLENT TEST-RETEST RELIABILITY IN EARLY, UNTREATED PSORIATIC ARTHRITIS

被引:0
|
作者
De Marco, Gabriele [1 ,2 ]
Hensor, Elizabeth M. A. [1 ,2 ]
McGonagle, Dennis G. [1 ,2 ]
Tan, Ai Lyn [1 ,2 ]
Coates, Laura C. [3 ]
Emery, Paul [1 ,2 ]
Helliwell, Philip S. [1 ,2 ]
Ortega, Helena Marzo [1 ,2 ]
机构
[1] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[3] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Leeds, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E072
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Fatigue in psoriatic arthritis: Is it related to disease activity?
    Lai, Tin Lok
    Au, Chi Kit
    Chung, Ho Yin
    Leung, Man Chi
    Ng, Woon Leung
    Lau, Chak Sing
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (03) : 418 - 425
  • [42] Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis
    Concepción Moll
    Mónica Bogas
    José A. Gómez-Puerta
    Raquel Celis
    Ivonne Vázquez
    Fernando Rodríguez
    Eduardo Kanterewicz
    Raimón Sanmarti
    Juan D. Cañete
    Clinical Rheumatology, 2009, 28 : 1053 - 1057
  • [43] FURTHER ANALYSIS OF PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE (PASDAS) AND COMPOSITE PSORIATIC DISEASE ACTIVITY INDEX (CPDAI) USING DATA FROM A PLACEBO-CONTROLLED TRIAL OF CERTOLIZUMAB PEGOL IN PSORIATIC ARTHRITIS
    Helliwell, P.
    Mease, P. J.
    Nurminen, T.
    FitzGerald, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 740 - 740
  • [44] Implementing Psoriatic Arthritis Disease Activity Score-guided treat-to-target in psoriatic arthritis routine clinical practice: (im)possible?
    Mulder, Michelle L. M.
    den Broeder, Alfons A.
    van Ginneken, Berbke T. J.
    Mahler, Elien A. M.
    van den Hoogen, Frank H. J.
    Vriezekolk, Johanna E.
    Wenink, Mark H.
    RHEUMATOLOGY, 2019, 58 (12) : 2330 - 2331
  • [45] DEFINING THE THERAPEUTIC TARGET IN PSORIATIC ARTHRITIS: ASSOCIATION BETWEEN MINIMAL DISEASE ACTIVITY (MDA) AND DISEASE ACTIVITY IN PSORIATIC ARTHRITIS (DAPSA)
    Coronel Ale, A. L.
    Cerda, O. L.
    Fornaro, M. N.
    Isnardi, C. A.
    Schneeberger, E. E.
    Citera, G.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S117 - S118
  • [46] Development of a Disease Activity and Responder Index for Psoriatic Arthritis - Report of the Psoriatic Arthritis Module at OMERACT 11
    Coates, Laura C.
    FitzGerald, Oliver
    Mease, Philip J.
    Gladman, Dafna D.
    Strand, Vibeke
    Goel, Niti
    Campbell, Ina
    Krueger, Gerald
    McHugh, Neil J.
    Helliwell, Philip S.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 782 - 791
  • [47] Comparison of disease activity measures in early psoriatic arthritis in usual care
    Wervers, Kim
    Luime, Jolanda J.
    Tchetverikov, Ilja
    Gerards, Andreas H.
    Kok, Marc R.
    Appels, Cathelijne W. Y.
    van der Graaff, Wiebo L.
    van Groenendael, Johannes H. L. M.
    Korswagen, Lindy-Anne
    Veris-van Dieren, Josien J.
    Hazes, Johanna M. W.
    Vis, Marijn
    RHEUMATOLOGY, 2019, 58 (12) : 2251 - 2259
  • [48] Treating Psoriatic Arthritis (PsA) to Target: Defining Psoriatic Arthritis Disease Activity Score (PASDAS) that Reflects High, Moderate and Low Disease Activity as well as Minimal Disease Activity (MDA) in PsA
    Got, Matthew
    Li, Suzanne
    Perruccio, Anthony
    Gladman, Dafna
    Chandran, Vinod
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1220 - 1221
  • [49] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Arthur Kavanaugh
    Rakesh Singh
    Chitra Karki
    Carol J. Etzel
    Joel M. Kremer
    Jeffrey D. Greenberg
    Jenny Griffith
    Clinical Rheumatology, 2018, 37 : 2275 - 2280
  • [50] Disease activity and biologic use in patients with psoriatic arthritis or rheumatoid arthritis
    Kavanaugh, Arthur
    Singh, Rakesh
    Karki, Chitra
    Etzel, Carol J.
    Kremer, Joel M.
    Greenberg, Jeffrey D.
    Griffith, Jenny
    CLINICAL RHEUMATOLOGY, 2018, 37 (08) : 2275 - 2280